METTL17 and cancer: Further, comprehensive analysis of another two databases, Cancer Dependency Map (DepMap) [43] and Cancer Cell Line Encyclopedia (CCLE) [44], demonstrate that the protein level of METTL17 is positively associated to ML162 and RSL3 AUC drug sensitivity across various cancer cell lines (Fig. 1B and C).